IDH1 and acute myeloid leukemia: A study found that IDH-mutant AML cells exhibit enhanced mitochondrial oxidative metabolism and that fatty acid oxidation in IDH-mutant cells is further increased with increased TCA cycle products (Stuani et al., 2021).